SOHO 最新进展更新与后续问题:T-ALL 新型疗法:从 CAR-T 到新靶点
SOHO State of the Art Updates and Next Questions: Novel Therapies in T-ALL: From CAR-T to Novel Targets.
52.2分
★★★☆☆
站内排序·非疗效
FRONTIER PAPERS
SOHO State of the Art Updates and Next Questions: Novel Therapies in T-ALL: From CAR-T to Novel Targets.
Cellular and humoral immunotherapy in children, adolescents and young adults with non-Hodgkin lymphoma.
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。